These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38336771)

  • 21. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
    Ferracin M; Pedriali M; Veronese A; Zagatti B; Gafà R; Magri E; Lunardi M; Munerato G; Querzoli G; Maestri I; Ulazzi L; Nenci I; Croce CM; Lanza G; Querzoli P; Negrini M
    J Pathol; 2011 Sep; 225(1):43-53. PubMed ID: 21630269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary.
    Conway AM; Pearce SP; Clipson A; Hill SM; Chemi F; Slane-Tan D; Ferdous S; Hossain ASMM; Kamieniecka K; White DJ; Mitchell C; Kerr A; Krebs MG; Brady G; Dive C; Cook N; Rothwell DG
    Nat Commun; 2024 Apr; 15(1):3292. PubMed ID: 38632274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient identification of miRNAs for classification of tumor origin.
    Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
    J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.
    Tothill RW; Li J; Mileshkin L; Doig K; Siganakis T; Cowin P; Fellowes A; Semple T; Fox S; Byron K; Kowalczyk A; Thomas D; Schofield P; Bowtell DD
    J Pathol; 2013 Dec; 231(4):413-23. PubMed ID: 24037760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples.
    Mattesen TB; Andersen CL; Bramsen JB
    Clin Epigenetics; 2021 Jan; 13(1):20. PubMed ID: 33509261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.
    Nguyen L; Van Hoeck A; Cuppen E
    Nat Commun; 2022 Jul; 13(1):4013. PubMed ID: 35817764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studies.
    Wong EM; Joo JE; McLean CA; Baglietto L; English DR; Severi G; Hopper JL; Milne RL; FitzGerald LM; Giles GG; Southey MC
    BMC Res Notes; 2015 Oct; 8():543. PubMed ID: 26438025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of methylation capture sequencing and Infinium MethylationEPIC array in peripheral blood mononuclear cells.
    Shu C; Zhang X; Aouizerat BE; Xu K
    Epigenetics Chromatin; 2020 Nov; 13(1):51. PubMed ID: 33228774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of clinical formalin-fixed paraffin-embedded tissue quality for targeted-bisulfite sequencing.
    Ohmomo H; Komaki S; Ono K; Sutoh Y; Hachiya T; Arai E; Fujimoto H; Yoshida T; Kanai Y; Sasaki M; Shimizu A
    Pathol Int; 2021 Feb; 71(2):135-140. PubMed ID: 33333623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process.
    Wen X; Jeong S; Kim Y; Bae JM; Cho NY; Kim JH; Kang GH
    Clin Epigenetics; 2017; 9():1. PubMed ID: 28149329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A streamlined method for analysing genome-wide DNA methylation patterns from low amounts of FFPE DNA.
    Ludgate JL; Wright J; Stockwell PA; Morison IM; Eccles MR; Chatterjee A
    BMC Med Genomics; 2017 Aug; 10(1):54. PubMed ID: 28859641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation.
    Zhang CD; Takeshima H; Sekine S; Yamashita S; Liu YY; Hattori N; Abe H; Yamashita H; Fukuda M; Imamura Y; Ushiku T; Katai H; Makino H; Watanabe M; Seto Y; Ushijima T
    Gastric Cancer; 2022 Mar; 25(2):336-345. PubMed ID: 34557982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation.
    Xia D; Leon AJ; Cabanero M; Pugh TJ; Tsao MS; Rath P; Siu LL; Yu C; Bedard PL; Shepherd FA; Zadeh G; Chetty R; Aldape K
    Mod Pathol; 2020 Oct; 33(10):1874-1888. PubMed ID: 32415265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fresh and frozen cardiac tissue are comparable in DNA methylation array β-values, but formalin-fixed, paraffin-embedded tissue may overestimate DNA methylation levels.
    Dupont ME; Jacobsen SB; Christiansen SNN; Tfelt-Hansen J; Smerup MH; Andersen JD; Morling N
    Sci Rep; 2023 Sep; 13(1):16381. PubMed ID: 37773256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary
    Dermawan JK; Rubin BP
    Semin Diagn Pathol; 2021 Nov; 38(6):193-198. PubMed ID: 33309276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).
    Vibert J; Pierron G; Benoist C; Gruel N; Guillemot D; Vincent-Salomon A; Le Tourneau C; Livartowski A; Mariani O; Baulande S; Bidard FC; Delattre O; Waterfall JJ; Watson S
    J Mol Diagn; 2021 Oct; 23(10):1380-1392. PubMed ID: 34325056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.